Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zenlabs Ethica's share price for the quarter that ended in Mar. 2026 was ₹17.37. Zenlabs Ethica's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 6.5 Mil. Therefore, Zenlabs Ethica's market cap for the quarter that ended in Mar. 2026 was ₹113.1 Mil.
Zenlabs Ethica's quarterly market cap
declined
from Sep. 2025 (₹192.2 Mil) to Dec. 2025 (₹129.5 Mil) and
declined
from Dec. 2025 (₹129.5 Mil) to Mar. 2026 (₹113.1 Mil).
Zenlabs Ethica's annual market cap
declined
from Mar. 2024 (₹270.2 Mil) to Mar. 2025 (₹203.2 Mil) and
declined
from Mar. 2025 (₹203.2 Mil) to Mar. 2026 (₹113.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zenlabs Ethica's Enterprise Value for Today is ₹305.4 Mil.
Zenlabs Ethica (BOM:530697) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zenlabs Ethica Market Cap Related Terms
Zenlabs Ethica Market Cap Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: Market Cap Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Market Cap distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zenlabs Ethica's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenlabs Ethica (BOM:530697) has a Market Cap of ₹226.9 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zenlabs Ethica and its competitors. According to the industry distribution chart, Zenlabs Ethica ranks #115 out of 120 companies in the Medical Distribution industry, placing it in the top 95.8%.
Is Zenlabs Ethica's Market Cap too high?
Zenlabs Ethica's current Market Cap is ₹226.9 Mil. Based on the distribution chart, Zenlabs Ethica ranks #115 out of 120 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Zenlabs Ethica has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #115 out of 120 companies for Market Cap. This places Zenlabs Ethica in the lower half of its industry. The industry median Market Cap is 146.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 146.94, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Market Cap is 146.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Market Cap is ₹226.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹29.26, compared to a current price of ₹34.85 — trading 19.1% above its estimated fair value. The current Market Cap is ₹226.9 Mil. Zenlabs Ethica's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Market Cap is ₹226.9 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹34.85 is trading 19.1% above its estimated GF Value™ of ₹29.26.
GuruFocus considers Zenlabs Ethica to be Modestly Overvalued.
Key valuation signals for BOM:530697:
Market Cap: ₹226.9 Mil
GF Value™: ₹29.26 vs. price of ₹34.85 (19.1% above fair value)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
60GF Score
Get the complete analysis for BOM:530697
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
